Risk of blood clot is 'one in a million,' says Professor, as jab trial in children is paused
THE trial of the Oxford/AstraZeneca vaccine in children has been paused while regulators investigate reports of a rare form of blood clot among adults. The University of Oxford said that no safety concerns have arisen from the trial itself.